AdaptHealth Corp. (AHCO) Q3 2025 Earnings Call Transcript
AdaptHealth Corp. ( AHCO ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Suzanne Foster - CEO & Director Jason Clemens - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Brian Tanquilut - Jefferies LLC, Research Division Richard Close - Canaccord Genuity Corp., Research Division Kieran Ryan - Deutsche Bank AG, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Presentation Operator Good day, everyone, and welcome to today's AdaptHealth Third Quarter 2025 Earnings Release.
AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
AdaptHealth Corp. (AHCO) Q2 2025 Earnings Call Transcript
AdaptHealth Corp. (NASDAQ:AHCO ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Jason A. Clemens - Chief Financial Officer Suzanne M.
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago.
AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?
AdaptHealth (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in AdaptHealth Stock?
Investors need to pay close attention to AHCO stock based on the movements in the options market lately.
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care
AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.
AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript
AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Suzanne Foster - CEO Jason Clemens - CFO Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Eric Coldwell - Baird Kevin Caliendo - UBS Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Whit Mayo - Leerink Partners John Pinney - Canaccord Genuity Operator Good day, everyone, and welcome to today's AdaptHealth First Quarter 2025 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.
AdaptHealth (AHCO) Upgraded to Buy: Here's What You Should Know
AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AHCO or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
My Sleep Apnea Has Led Me To Profits With AdaptHealth
AdaptHealth Corp specializes in sleep therapy equipment and respiratory health. These two focus segments also command the best margins for the company. Q4 2024 results exceeded expectations, driving a 30% stock surge; the company reported a record 12.3% operating income margin.
